Eledon Pharmaceuticals (ELDN) Net Income (2016 - 2017)
Historic Net Income for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q1 2017 value amounting to -$3.9 million.
- Eledon Pharmaceuticals' Net Income rose 6616.49% to -$3.9 million in Q1 2017 from the same period last year, while for Sep 2017 it was -$7.6 million, marking a year-over-year increase of 8319.37%. This contributed to the annual value of -$36.4 million for FY2024, which is 6883.4% up from last year.
- As of Q1 2017, Eledon Pharmaceuticals' Net Income stood at -$3.9 million, which was up 6616.49% from -$3.7 million recorded in Q4 2016.
- In the past 5 years, Eledon Pharmaceuticals' Net Income registered a high of -$3.7 million during Q4 2016, and its lowest value of -$13.5 million during Q2 2016.
- Over the past 5 years, Eledon Pharmaceuticals' median Net Income value was -$7.7 million (recorded in 2014), while the average stood at -$8.3 million.
- Its Net Income has fluctuated over the past 5 years, first plummeted by 17357.13% in 2015, then skyrocketed by 6616.49% in 2017.
- Eledon Pharmaceuticals' Net Income (Quarter) stood at -$5.5 million in 2013, then fell by 11.88% to -$6.2 million in 2014, then plummeted by 77.46% to -$11.0 million in 2015, then surged by 66.08% to -$3.7 million in 2016, then dropped by 3.45% to -$3.9 million in 2017.
- Its Net Income was -$3.9 million in Q1 2017, compared to -$3.7 million in Q4 2016 and -$9.3 million in Q3 2016.